KENNEDY ONYENWE: Open Payments
NPI 1760021604 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 32 payments from 7 companies in 2025. Trend: 2023 $335 · 2024 $572 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $380 |
| Alkermes, Inc. | 10 | $345 |
| Lundbeck LLC | 2 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, ARISTADA, LYBALVI, REXULTI, UZEDY, ABILIFY ASIMTUFII, COBENFY, FANAPT.
Industry payments across NY — which companies pay providers there.
